Shopping Cart
- Remove All
- Your shopping cart is currently empty
PZ703b TFA, a Bcl-xl PROTAC degradation agent, promotes apoptosis and halts bladder cancer cell proliferation, making it a pertinent investigative compound for related oncological studies [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | PZ703b TFA, a Bcl-xl PROTAC degradation agent, promotes apoptosis and halts bladder cancer cell proliferation, making it a pertinent investigative compound for related oncological studies [1] [2]. |
In vitro | PZ703b (0-1 μM, 24 h) TFA synergistically enhances the anti-proliferative effects of Mivebresib against bladder cancer cells in a dose-responsive manner while inducing apoptosis through the mitochondrial pathway [1]. PZ703b (0-1 μM, 48 h) TFA also potently inhibits MOLT-4 and RS4;11 cell lines, with IC50 values of 15.9 and 11.3 nM, respectively [2]. At 10 nM over 48 hours, PZ703b TFA induces significant and sustained BCL-XL degradation, leading to caspase-3 mediated apoptosis in MOLT-4 cells [2]. |
Molecular Weight | 1714.46 |
Formula | C82H103ClF6N10O13S4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.